Rui Fernandes

2.7k citations
63 papers · 2.1k indexed · h-index 27
Topics
Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers)Alzheimer's disease research and treatments (7 papers)Nanoparticle-Based Drug Delivery (5 papers)

In The Last Decade

Rui Fernandes

60 papers receiving 2.1k citations

Peers

Rui Fernandes
Comparison fields: 5 of 139
  • Molecular Biology 1.0k
  • Physiology 372
  • Cell Biology 305
  • Biomedical Engineering 216
  • Biomaterials 177
Replace Shu‐Huei Wang with:
Shu‐Huei Wang Taiwan
Yiping Li China
Xiaoli Ma China
Shweta Sharma India
Yi Liang China
Monica Emanuelli Italy
Michael K. Dame United States
Arnaud Bianchi France
Siwei Wang China
Chan Woo Kim South Korea
Rui Fernandes relative to Shu‐Huei Wang Taiwan Shu‐Huei Wang's profile →
Citations per field
00.5×1.5×
Shu‐Huei Wang · 1×
Citations per year

Countries citing papers authored by Rui Fernandes

Since Specialization
Citations

This map shows the geographic impact of Rui Fernandes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Fernandes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Fernandes more than expected).

Fields of papers citing papers by Rui Fernandes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Fernandes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Fernandes. The network helps show where Rui Fernandes may publish in the future.

Co-authorship network of co-authors of Rui Fernandes

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Fernandes. A scholar is included among the top collaborators of Rui Fernandes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Fernandes. Rui Fernandes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 30
4 11
5 9
6 14
7 1
8 53
9 7
10 16
11 26
12 11
13 23
14 12
15 69
16 17
17 46
18 25
19 266
20 52

About Rui Fernandes

Rui Fernandes is a scholar working on Cell Biology, Biomaterials and Aging, having authored 63 papers that have together received 2.1k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Alzheimer's disease research and treatments (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). The work is most often cited by research in Cell Biology (305 citations), Genetics (174 citations) and Molecular Biology (1.0k citations). Rui Fernandes has collaborated with scholars based in Portugal, United Kingdom and United States. Frequent co-authors include Maria João Saraiva, Mónica Mendes Sousa, António Guimarães, Isabel Cardoso, Joana Almeida Palha, Francisco Figueiredo, Shi Du Yan, David Stern, Paula Sampaio and Sofia Duque Santos. Their work appears in journals such as Nature Communications, Journal of Neuroscience and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026